-
Description

-
Table of Contents

-
Table of Figures

-
Related Reports

PDF Download 
-
Description

-
Table of Contents

-
Table of Figures

-
Related Reports

PDF Download 
Description
Chronic obstructive pulmonary disease (COPD) is kind of lung disease which happen due to chronic obstruction of lung airflow that interferes with normal breathing and is not fully reversible.
Market Analysis and Insights: Global Emphysema Treatment Market
The global Emphysema Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Emphysema Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Emphysema Treatment, also provides the revenue of main regions and countries. of the upcoming market potential for Emphysema Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Emphysema Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Emphysema Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Emphysema Treatment revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pulmonx, Bioxyne, Intrexon, Icure Pharmaceuticals, Kamada, Emphasys Medical, Pfizer, Olympus and BTG, etc.
Market Segmentation
Report Metric
Details
Report Title
Global Emphysema Treatment Market Insights, Forecast to 2030
Global Emphysema Treatment Companies Covered
Pulmonx, Bioxyne, Intrexon, Icure Pharmaceuticals, Kamada, Emphasys Medical, Pfizer, Olympus, BTG, PneumRx and Uptake Medical, Halozyme Therapeutics, Mariposa Health, Uptake Medical
Global Emphysema Treatment Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Emphysema Treatment Market, Segment by Type
Global Emphysema Treatment Market, Segment by Application
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Emphysema Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Emphysema Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Emphysema Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Emphysema Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Centrilobular emphysema
1.2.3 Panlobular emphysema
1.3 Market by Application
1.3.1 Global Emphysema Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Surgical center
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Emphysema Treatment Market Perspective (2019-2030)
2.2 Global Emphysema Treatment Growth Trends by Region
2.2.1 Emphysema Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Emphysema Treatment Historic Market Size by Region (2019-2024)
2.2.3 Emphysema Treatment Forecasted Market Size by Region (2025-2030)
2.3 Emphysema Treatment Market Dynamics
2.3.1 Emphysema Treatment Industry Trends
2.3.2 Emphysema Treatment Market Drivers
2.3.3 Emphysema Treatment Market Challenges
2.3.4 Emphysema Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Emphysema Treatment by Players
3.1.1 Global Emphysema Treatment Revenue by Players (2019-2024)
3.1.2 Global Emphysema Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Emphysema Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Emphysema Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Emphysema Treatment Market Concentration Ratio
3.4.1 Global Emphysema Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Emphysema Treatment Revenue in 2023
3.5 Global Key Players of Emphysema Treatment Head office and Area Served
3.6 Global Key Players of Emphysema Treatment, Product and Application
3.7 Global Key Players of Emphysema Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Emphysema Treatment Breakdown Data by Type
4.1 Global Emphysema Treatment Historic Market Size by Type (2019-2024)
4.2 Global Emphysema Treatment Forecasted Market Size by Type (2025-2030)
5 Emphysema Treatment Breakdown Data by Application
5.1 Global Emphysema Treatment Historic Market Size by Application (2019-2024)
5.2 Global Emphysema Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Emphysema Treatment Market Size (2019-2030)
6.2 North America Emphysema Treatment Market Size by Type
6.2.1 North America Emphysema Treatment Market Size by Type (2019-2024)
6.2.2 North America Emphysema Treatment Market Size by Type (2025-2030)
6.2.3 North America Emphysema Treatment Market Share by Type (2019-2030)
6.3 North America Emphysema Treatment Market Size by Application
6.3.1 North America Emphysema Treatment Market Size by Application (2019-2024)
6.3.2 North America Emphysema Treatment Market Size by Application (2025-2030)
6.3.3 North America Emphysema Treatment Market Share by Application (2019-2030)
6.4 North America Emphysema Treatment Market Size by Country
6.4.1 North America Emphysema Treatment Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Emphysema Treatment Market Size by Country (2019-2024)
6.4.3 North America Emphysema Treatment Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Emphysema Treatment Market Size (2019-2030)
7.2 Europe Emphysema Treatment Market Size by Type
7.2.1 Europe Emphysema Treatment Market Size by Type (2019-2024)
7.2.2 Europe Emphysema Treatment Market Size by Type (2025-2030)
7.2.3 Europe Emphysema Treatment Market Share by Type (2019-2030)
7.3 Europe Emphysema Treatment Market Size by Application
7.3.1 Europe Emphysema Treatment Market Size by Application (2019-2024)
7.3.2 Europe Emphysema Treatment Market Size by Application (2025-2030)
7.3.3 Europe Emphysema Treatment Market Share by Application (2019-2030)
7.4 Europe Emphysema Treatment Market Size by Country
7.4.1 Europe Emphysema Treatment Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Emphysema Treatment Market Size by Country (2019-2024)
7.4.3 Europe Emphysema Treatment Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Emphysema Treatment Market Size (2019-2030)
8.2 China Emphysema Treatment Market Size by Type
8.2.1 China Emphysema Treatment Market Size by Type (2019-2024)
8.2.2 China Emphysema Treatment Market Size by Type (2025-2030)
8.2.3 China Emphysema Treatment Market Share by Type (2019-2030)
8.3 China Emphysema Treatment Market Size by Application
8.3.1 China Emphysema Treatment Market Size by Application (2019-2024)
8.3.2 China Emphysema Treatment Market Size by Application (2025-2030)
8.3.3 China Emphysema Treatment Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Emphysema Treatment Market Size (2019-2030)
9.2 Asia Emphysema Treatment Market Size by Type
9.2.1 Asia Emphysema Treatment Market Size by Type (2019-2024)
9.2.2 Asia Emphysema Treatment Market Size by Type (2025-2030)
9.2.3 Asia Emphysema Treatment Market Share by Type (2019-2030)
9.3 Asia Emphysema Treatment Market Size by Application
9.3.1 Asia Emphysema Treatment Market Size by Application (2019-2024)
9.3.2 Asia Emphysema Treatment Market Size by Application (2025-2030)
9.3.3 Asia Emphysema Treatment Market Share by Application (2019-2030)
9.4 Asia Emphysema Treatment Market Size by Region
9.4.1 Asia Emphysema Treatment Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Emphysema Treatment Market Size by Region (2019-2024)
9.4.3 Asia Emphysema Treatment Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Emphysema Treatment Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Emphysema Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Emphysema Treatment Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Emphysema Treatment Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Emphysema Treatment Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Emphysema Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Emphysema Treatment Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Emphysema Treatment Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Emphysema Treatment Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Emphysema Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Emphysema Treatment Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Emphysema Treatment Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Emphysema Treatment Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pulmonx
11.1.1 Pulmonx Company Details
11.1.2 Pulmonx Business Overview
11.1.3 Pulmonx Emphysema Treatment Introduction
11.1.4 Pulmonx Revenue in Emphysema Treatment Business (2019-2024)
11.1.5 Pulmonx Recent Developments
11.2 Bioxyne
11.2.1 Bioxyne Company Details
11.2.2 Bioxyne Business Overview
11.2.3 Bioxyne Emphysema Treatment Introduction
11.2.4 Bioxyne Revenue in Emphysema Treatment Business (2019-2024)
11.2.5 Bioxyne Recent Developments
11.3 Intrexon
11.3.1 Intrexon Company Details
11.3.2 Intrexon Business Overview
11.3.3 Intrexon Emphysema Treatment Introduction
11.3.4 Intrexon Revenue in Emphysema Treatment Business (2019-2024)
11.3.5 Intrexon Recent Developments
11.4 Icure Pharmaceuticals
11.4.1 Icure Pharmaceuticals Company Details
11.4.2 Icure Pharmaceuticals Business Overview
11.4.3 Icure Pharmaceuticals Emphysema Treatment Introduction
11.4.4 Icure Pharmaceuticals Revenue in Emphysema Treatment Business (2019-2024)
11.4.5 Icure Pharmaceuticals Recent Developments
11.5 Kamada
11.5.1 Kamada Company Details
11.5.2 Kamada Business Overview
11.5.3 Kamada Emphysema Treatment Introduction
11.5.4 Kamada Revenue in Emphysema Treatment Business (2019-2024)
11.5.5 Kamada Recent Developments
11.6 Emphasys Medical
11.6.1 Emphasys Medical Company Details
11.6.2 Emphasys Medical Business Overview
11.6.3 Emphasys Medical Emphysema Treatment Introduction
11.6.4 Emphasys Medical Revenue in Emphysema Treatment Business (2019-2024)
11.6.5 Emphasys Medical Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Emphysema Treatment Introduction
11.7.4 Pfizer Revenue in Emphysema Treatment Business (2019-2024)
11.7.5 Pfizer Recent Developments
11.8 Olympus
11.8.1 Olympus Company Details
11.8.2 Olympus Business Overview
11.8.3 Olympus Emphysema Treatment Introduction
11.8.4 Olympus Revenue in Emphysema Treatment Business (2019-2024)
11.8.5 Olympus Recent Developments
11.9 BTG
11.9.1 BTG Company Details
11.9.2 BTG Business Overview
11.9.3 BTG Emphysema Treatment Introduction
11.9.4 BTG Revenue in Emphysema Treatment Business (2019-2024)
11.9.5 BTG Recent Developments
11.10 PneumRx and Uptake Medical
11.10.1 PneumRx and Uptake Medical Company Details
11.10.2 PneumRx and Uptake Medical Business Overview
11.10.3 PneumRx and Uptake Medical Emphysema Treatment Introduction
11.10.4 PneumRx and Uptake Medical Revenue in Emphysema Treatment Business (2019-2024)
11.10.5 PneumRx and Uptake Medical Recent Developments
11.11 Halozyme Therapeutics
11.11.1 Halozyme Therapeutics Company Details
11.11.2 Halozyme Therapeutics Business Overview
11.11.3 Halozyme Therapeutics Emphysema Treatment Introduction
11.11.4 Halozyme Therapeutics Revenue in Emphysema Treatment Business (2019-2024)
11.11.5 Halozyme Therapeutics Recent Developments
11.12 Mariposa Health
11.12.1 Mariposa Health Company Details
11.12.2 Mariposa Health Business Overview
11.12.3 Mariposa Health Emphysema Treatment Introduction
11.12.4 Mariposa Health Revenue in Emphysema Treatment Business (2019-2024)
11.12.5 Mariposa Health Recent Developments
11.13 Uptake Medical
11.13.1 Uptake Medical Company Details
11.13.2 Uptake Medical Business Overview
11.13.3 Uptake Medical Emphysema Treatment Introduction
11.13.4 Uptake Medical Revenue in Emphysema Treatment Business (2019-2024)
11.13.5 Uptake Medical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table of Figures
List of Tables
Table 1. Global Emphysema Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Centrilobular emphysema
Table 3. Key Players of Panlobular emphysema
Table 4. Global Emphysema Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Global Emphysema Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Emphysema Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Emphysema Treatment Market Share by Region (2019-2024)
Table 8. Global Emphysema Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Emphysema Treatment Market Share by Region (2025-2030)
Table 10. Emphysema Treatment Market Trends
Table 11. Emphysema Treatment Market Drivers
Table 12. Emphysema Treatment Market Challenges
Table 13. Emphysema Treatment Market Restraints
Table 14. Global Emphysema Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Emphysema Treatment Revenue Share by Players (2019-2024)
Table 16. Global Top Emphysema Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Emphysema Treatment as of 2023)
Table 17. Global Emphysema Treatment Industry Ranking 2022 VS 2023 VS 2024
Table 18. Global 5 Largest Players Market Share by Emphysema Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Emphysema Treatment, Headquarters and Area Served
Table 20. Global Key Players of Emphysema Treatment, Product and Application
Table 21. Global Key Players of Emphysema Treatment, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Emphysema Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Emphysema Treatment Revenue Market Share by Type (2019-2024)
Table 25. Global Emphysema Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Emphysema Treatment Revenue Market Share by Type (2025-2030)
Table 27. Global Emphysema Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Emphysema Treatment Revenue Share by Application (2019-2024)
Table 29. Global Emphysema Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Emphysema Treatment Revenue Share by Application (2025-2030)
Table 31. North America Emphysema Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 32. North America Emphysema Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 33. North America Emphysema Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 34. North America Emphysema Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 35. North America Emphysema Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Emphysema Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Emphysema Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Emphysema Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 39. Europe Emphysema Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 40. Europe Emphysema Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 41. Europe Emphysema Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 42. Europe Emphysema Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Europe Emphysema Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 44. Europe Emphysema Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 45. China Emphysema Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 46. China Emphysema Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 47. China Emphysema Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 48. China Emphysema Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 49. Asia Emphysema Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 50. Asia Emphysema Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 51. Asia Emphysema Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 52. Asia Emphysema Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia Emphysema Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 54. Asia Emphysema Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 55. Asia Emphysema Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Emphysema Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Emphysema Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Emphysema Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Emphysema Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Emphysema Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 61. Middle East, Africa, and Latin America Emphysema Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Emphysema Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 63. Pulmonx Company Details
Table 64. Pulmonx Business Overview
Table 65. Pulmonx Emphysema Treatment Product
Table 66. Pulmonx Revenue in Emphysema Treatment Business (2019-2024) & (US$ Million)
Table 67. Pulmonx Recent Developments
Table 68. Bioxyne Company Details
Table 69. Bioxyne Business Overview
Table 70. Bioxyne Emphysema Treatment Product
Table 71. Bioxyne Revenue in Emphysema Treatment Business (2019-2024) & (US$ Million)
Table 72. Bioxyne Recent Developments
Table 73. Intrexon Company Details
Table 74. Intrexon Business Overview
Table 75. Intrexon Emphysema Treatment Product
Table 76. Intrexon Revenue in Emphysema Treatment Business (2019-2024) & (US$ Million)
Table 77. Intrexon Recent Developments
Table 78. Icure Pharmaceuticals Company Details
Table 79. Icure Pharmaceuticals Business Overview
Table 80. Icure Pharmaceuticals Emphysema Treatment Product
Table 81. Icure Pharmaceuticals Revenue in Emphysema Treatment Business (2019-2024) & (US$ Million)
Table 82. Icure Pharmaceuticals Recent Developments
Table 83. Kamada Company Details
Table 84. Kamada Business Overview
Table 85. Kamada Emphysema Treatment Product
Table 86. Kamada Revenue in Emphysema Treatment Business (2019-2024) & (US$ Million)
Table 87. Kamada Recent Developments
Table 88. Emphasys Medical Company Details
Table 89. Emphasys Medical Business Overview
Table 90. Emphasys Medical Emphysema Treatment Product
Table 91. Emphasys Medical Revenue in Emphysema Treatment Business (2019-2024) & (US$ Million)
Table 92. Emphasys Medical Recent Developments
Table 93. Pfizer Company Details
Table 94. Pfizer Business Overview
Table 95. Pfizer Emphysema Treatment Product
Table 96. Pfizer Revenue in Emphysema Treatment Business (2019-2024) & (US$ Million)
Table 97. Pfizer Recent Developments
Table 98. Olympus Company Details
Table 99. Olympus Business Overview
Table 100. Olympus Emphysema Treatment Product
Table 101. Olympus Revenue in Emphysema Treatment Business (2019-2024) & (US$ Million)
Table 102. Olympus Recent Developments
Table 103. BTG Company Details
Table 104. BTG Business Overview
Table 105. BTG Emphysema Treatment Product
Table 106. BTG Revenue in Emphysema Treatment Business (2019-2024) & (US$ Million)
Table 107. BTG Recent Developments
Table 108. PneumRx and Uptake Medical Company Details
Table 109. PneumRx and Uptake Medical Business Overview
Table 110. PneumRx and Uptake Medical Emphysema Treatment Product
Table 111. PneumRx and Uptake Medical Revenue in Emphysema Treatment Business (2019-2024) & (US$ Million)
Table 112. PneumRx and Uptake Medical Recent Developments
Table 113. Halozyme Therapeutics Company Details
Table 114. Halozyme Therapeutics Business Overview
Table 115. Halozyme Therapeutics Emphysema Treatment Product
Table 116. Halozyme Therapeutics Revenue in Emphysema Treatment Business (2019-2024) & (US$ Million)
Table 117. Halozyme Therapeutics Recent Developments
Table 118. Mariposa Health Company Details
Table 119. Mariposa Health Business Overview
Table 120. Mariposa Health Emphysema Treatment Product
Table 121. Mariposa Health Revenue in Emphysema Treatment Business (2019-2024) & (US$ Million)
Table 122. Mariposa Health Recent Developments
Table 123. Uptake Medical Company Details
Table 124. Uptake Medical Business Overview
Table 125. Uptake Medical Emphysema Treatment Product
Table 126. Uptake Medical Revenue in Emphysema Treatment Business (2019-2024) & (US$ Million)
Table 127. Uptake Medical Recent Developments
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Emphysema Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Emphysema Treatment Market Share by Type: 2023 VS 2030
Figure 3. Centrilobular emphysema Features
Figure 4. Panlobular emphysema Features
Figure 5. Global Emphysema Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 6. Global Emphysema Treatment Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Clinics Case Studies
Figure 9. Surgical center Case Studies
Figure 10. Emphysema Treatment Report Years Considered
Figure 11. Global Emphysema Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Emphysema Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Emphysema Treatment Market Share by Region: 2023 VS 2030
Figure 14. Global Emphysema Treatment Market Share by Players in 2023
Figure 15. Global Top Emphysema Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Emphysema Treatment as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Emphysema Treatment Revenue in 2023
Figure 17. North America Emphysema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Emphysema Treatment Market Share by Type (2019-2030)
Figure 19. North America Emphysema Treatment Market Share by Application (2019-2030)
Figure 20. North America Emphysema Treatment Market Share by Country (2019-2030)
Figure 21. United States Emphysema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Emphysema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Emphysema Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 24. Europe Emphysema Treatment Market Share by Type (2019-2030)
Figure 25. Europe Emphysema Treatment Market Share by Application (2019-2030)
Figure 26. Europe Emphysema Treatment Market Share by Country (2019-2030)
Figure 27. Germany Emphysema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Emphysema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Emphysema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Emphysema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Emphysema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Emphysema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. China Emphysema Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 34. China Emphysema Treatment Market Share by Type (2019-2030)
Figure 35. China Emphysema Treatment Market Share by Application (2019-2030)
Figure 36. Asia Emphysema Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 37. Asia Emphysema Treatment Market Share by Type (2019-2030)
Figure 38. Asia Emphysema Treatment Market Share by Application (2019-2030)
Figure 39. Asia Emphysema Treatment Market Share by Region (2019-2030)
Figure 40. Japan Emphysema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. South Korea Emphysema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. China Taiwan Emphysema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Emphysema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. India Emphysema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Australia Emphysema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Emphysema Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Emphysema Treatment Market Share by Type (2019-2030)
Figure 48. Middle East, Africa, and Latin America Emphysema Treatment Market Share by Application (2019-2030)
Figure 49. Middle East, Africa, and Latin America Emphysema Treatment Market Share by Country (2019-2030)
Figure 50. Brazil Emphysema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Mexico Emphysema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Turkey Emphysema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Emphysema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Israel Emphysema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. GCC Countries Emphysema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Pulmonx Revenue Growth Rate in Emphysema Treatment Business (2019-2024)
Figure 57. Bioxyne Revenue Growth Rate in Emphysema Treatment Business (2019-2024)
Figure 58. Intrexon Revenue Growth Rate in Emphysema Treatment Business (2019-2024)
Figure 59. Icure Pharmaceuticals Revenue Growth Rate in Emphysema Treatment Business (2019-2024)
Figure 60. Kamada Revenue Growth Rate in Emphysema Treatment Business (2019-2024)
Figure 61. Emphasys Medical Revenue Growth Rate in Emphysema Treatment Business (2019-2024)
Figure 62. Pfizer Revenue Growth Rate in Emphysema Treatment Business (2019-2024)
Figure 63. Olympus Revenue Growth Rate in Emphysema Treatment Business (2019-2024)
Figure 64. BTG Revenue Growth Rate in Emphysema Treatment Business (2019-2024)
Figure 65. PneumRx and Uptake Medical Revenue Growth Rate in Emphysema Treatment Business (2019-2024)
Figure 66. Halozyme Therapeutics Revenue Growth Rate in Emphysema Treatment Business (2019-2024)
Figure 67. Mariposa Health Revenue Growth Rate in Emphysema Treatment Business (2019-2024)
Figure 68. Uptake Medical Revenue Growth Rate in Emphysema Treatment Business (2019-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Description
Chronic obstructive pulmonary disease (COPD) is kind of lung disease which happen due to chronic obstruction of lung airflow that interferes with normal breathing and is not fully reversible.
Market Analysis and Insights: Global Emphysema Treatment Market
The global Emphysema Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Emphysema Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Emphysema Treatment, also provides the revenue of main regions and countries. of the upcoming market potential for Emphysema Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Emphysema Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Emphysema Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Emphysema Treatment revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pulmonx, Bioxyne, Intrexon, Icure Pharmaceuticals, Kamada, Emphasys Medical, Pfizer, Olympus and BTG, etc.
Market Segmentation
Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Emphysema Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Emphysema Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Emphysema Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Related Reports
-
The global Emphysema Treatment Medication market size was US$ 4266 million in 2024 and is forecast to a readjusted size of US$ 5331 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 110
USD 4250.00
(Single User License)
-
The global market for Emphysema Treatment Medication was estimated to be worth US$ 4266 million in 2024 and is forecast to a readjusted size of US$ 5331 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 131
USD 3950.00
(Single User License)
-
The global market for Emphysema Treatment Medication was valued at US$ 4266 million in the year 2024 and is projected to reach a revised size of US$ 5331 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Published: 2025-03-12
Pages: 100
USD 2900.00
(Single User License)
-
The global market for Emphysema Treatment was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-26
Pages: 104
USD 3950.00
(Single User License)
-
The global market for Emphysema Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-26
Pages: 83
USD 2900.00
(Single User License)
-
Emphysema is a chronic and progressive lung condition characterized by damage to the air sacs in the lungs, known as alveoli. This damage leads to the deterioration of the lung tissue and results in decreased elasticity, making it difficult to breathe. The primary cause of emphysema is long-term exposure to irritants, most commonly cigarette smoke, although other factors such as air pollution and genetic predisposition can also contribute. Symptoms of emphysema include shortness of breath, chronic coughing, wheezing, and tightness in the chest. Treatment for emphysema focuses on managing symptoms and slowing down the progression of the disease. Medication is the therapeutic interventions for emphysema treatment.
Published: 2024-04-21
Pages: 94
USD 2900.00
(Single User License)
-
Emphysema is a chronic and progressive lung condition characterized by damage to the air sacs in the lungs, known as alveoli. This damage leads to the deterioration of the lung tissue and results in decreased elasticity, making it difficult to breathe. The primary cause of emphysema is long-term exposure to irritants, most commonly cigarette smoke, although other factors such as air pollution and genetic predisposition can also contribute. Symptoms of emphysema include shortness of breath, chronic coughing, wheezing, and tightness in the chest. Treatment for emphysema focuses on managing symptoms and slowing down the progression of the disease. Medication is the therapeutic interventions for emphysema treatment.
Published: 2024-04-21
Pages: 133
USD 4350.00
(Single User License)
-
Emphysema is a chronic and progressive lung condition characterized by damage to the air sacs in the lungs, known as alveoli. This damage leads to the deterioration of the lung tissue and results in decreased elasticity, making it difficult to breathe. The primary cause of emphysema is long-term exposure to irritants, most commonly cigarette smoke, although other factors such as air pollution and genetic predisposition can also contribute. Symptoms of emphysema include shortness of breath, chronic coughing, wheezing, and tightness in the chest. Treatment for emphysema focuses on managing symptoms and slowing down the progression of the disease. Medication is the therapeutic interventions for emphysema treatment.
Published: 2024-04-21
Pages: 157
USD 4900.00
(Single User License)
-
Emphysema is a chronic and progressive lung condition characterized by damage to the air sacs in the lungs, known as alveoli. This damage leads to the deterioration of the lung tissue and results in decreased elasticity, making it difficult to breathe. The primary cause of emphysema is long-term exposure to irritants, most commonly cigarette smoke, although other factors such as air pollution and genetic predisposition can also contribute. Symptoms of emphysema include shortness of breath, chronic coughing, wheezing, and tightness in the chest. Treatment for emphysema focuses on managing symptoms and slowing down the progression of the disease. Medication is the therapeutic interventions for emphysema treatment.
Published: 2024-04-21
Pages: 129
USD 3950.00
(Single User License)
-
Chronic obstructive pulmonary disease (COPD) is kind of lung disease which happen due to chronic obstruction of lung airflow that interferes with normal breathing and is not fully reversible.
Published: 2024-01-23
Pages: 179
USD 3950.00
(Single User License)